BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37866478)

  • 1. Circ-CCT2 Activates Wnt/β-catenin Signaling to Facilitate Hepatoblastoma Development by Stabilizing PTBP1 mRNA.
    Zhu Q; Hu Y; Jiang W; Ou ZL; Yao YB; Zai HY
    Cell Mol Gastroenterol Hepatol; 2024; 17(2):175-197. PubMed ID: 37866478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA OIP5-AS1 aggravates the stemness of hepatoblastoma through recruiting PTBP1 to increase the stability of β-catenin.
    Jiang W; Ou ZL; Zhu Q; Yao YB; Zai HY
    Pathol Res Pract; 2022 Apr; 232():153829. PubMed ID: 35255389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA SNHG4 enhances RNF14 mRNA stability to promote the progression of colorectal cancer by recruiting TAF15 protein.
    Lv L; Huang B; Yi L; Zhang L
    Apoptosis; 2023 Apr; 28(3-4):414-431. PubMed ID: 36482019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCT2 prevented β-catenin proteasomal degradation to sustain cancer stem cell traits and promote tumor progression in epithelial ovarian cancer.
    Chen J; Hu Q; Zhou C; Jin D
    Mol Biol Rep; 2024 Jan; 51(1):54. PubMed ID: 38165547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
    Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS
    Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal circ-AHCY promotes glioblastoma cell growth via Wnt/β-catenin signaling pathway.
    Li Y; Zheng X; Wang J; Sun M; Li D; Wang Z; Li J; Li Y; Liu Y
    Ann Clin Transl Neurol; 2023 Jun; 10(6):865-878. PubMed ID: 37150844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hsa_circ_001726 axis regulated by E2F6 contributes to metastasis of hepatocellular carcinoma.
    Ai J; Zhang W; Deng W; Yan L; Zhang L; Huang Z; Wu Z; Ai J; Jiang H
    BMC Cancer; 2024 Jan; 24(1):14. PubMed ID: 38166853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma.
    Sha YL; Liu S; Yan WW; Dong B
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31511432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
    Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
    Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircRNA has_circ_0017109 promotes lung tumor progression via activation of Wnt/β-catenin signaling due to modulating miR-671-5p/FZD4 axis.
    Yang B; Zhang B; Qi Q; Wang C
    BMC Pulm Med; 2022 Nov; 22(1):443. PubMed ID: 36434577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [hsa_circ_0000231 affects the progression of tongue squamous cell carcinoma by activating Wnt/β-catenin signaling pathway].
    Chen QW; Wang DQ; Ding BX; Tang MM; Li XG; Zhou JY; Xu K; Fang ZR; Han L; Wu H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Oct; 57(10):1230-1239. PubMed ID: 36319130
    [No Abstract]   [Full Text] [Related]  

  • 12. Hsa_circ_0026628 promotes the development of colorectal cancer by targeting SP1 to activate the Wnt/β-catenin pathway.
    Zhang X; Yao J; Shi H; Gao B; Zhou H; Zhang Y; Zhao D; Gao S; Wang C; Zhang L
    Cell Death Dis; 2021 Aug; 12(9):802. PubMed ID: 34420031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA circ_0068464 combined with microRNA-383 regulates Wnt/β-catenin pathway to promote the progression of colorectal cancer.
    Zou Y; Liu L; Meng J; Dai M
    Bioengineered; 2022 Mar; 13(3):5113-5125. PubMed ID: 35168468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Babao Dan is a robust anti-tumor agent via inhibiting wnt/β-catenin activation and cancer cell stemness.
    Xie X; Chen J; Wo D; Ma E; Ning Y; Peng J; Zhu W; Ren DN
    J Ethnopharmacol; 2021 Nov; 280():114449. PubMed ID: 34332067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
    Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
    J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KDM1A drives hepatoblastoma progression by activating the Wnt/β-catenin pathway through inhibition of DKK3 transcription.
    Ji C; Chen L; Yuan M; Xie W; Sheng X; Yin Q
    Tissue Cell; 2023 Apr; 81():101989. PubMed ID: 36642006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow stromal cell-derived exosomal circular RNA improves diabetic foot ulcer wound healing by activating the nuclear factor erythroid 2-related factor 2 pathway and inhibiting ferroptosis.
    Chen J; Li X; Liu H; Zhong D; Yin K; Li Y; Zhu L; Xu C; Li M; Wang C
    Diabet Med; 2023 Jul; 40(7):e15031. PubMed ID: 36537855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription activation of circ-STAT3 induced by Gli2 promotes the progression of hepatoblastoma via acting as a sponge for miR-29a/b/c-3p to upregulate STAT3/Gli2.
    Liu Y; Song J; Liu Y; Zhou Z; Wang X
    J Exp Clin Cancer Res; 2020 Jun; 39(1):101. PubMed ID: 32493490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
    Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa_circ_0003945 promotes progression of hepatocellular carcinoma by mediating miR-34c-5p/LGR4/β-catenin axis activity.
    Lyu LH; Zhang CY; Yang WJ; Jin AL; Zhu J; Wang H; Liu T; Wang BL; Cheng JW; Yang XR; Guo W
    J Cell Mol Med; 2022 Apr; 26(8):2218-2229. PubMed ID: 35170199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.